The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pharmacokinetic profile and receptor occupancy of avelumab (MSB0010718C), an anti-PD-L1 monoclonal antibody, in a phase I, open-label, dose escalation trial in patients with advanced solid tumors.
 
Christopher Ryan Heery
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Jennifer L. Marte
No Relationships to Disclose
 
Harpreet Singh
No Relationships to Disclose
 
Lisa M Cordes
No Relationships to Disclose
 
Ravi Amrit Madan
No Relationships to Disclose
 
Renee Nicole Donahue
No Relationships to Disclose
 
Italia Grenga
No Relationships to Disclose
 
Lauren Lepone
No Relationships to Disclose
 
Berend Neuteboom
Employment - Merck KGaA
 
Isabell Speit
Employment - Merck KGaA
 
Kevin M. Chin
Employment - Merck KGaA
 
Jeffrey Schlom
Research Funding - Merck KGaA (Inst)
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology